Codexis (CDXS) Payables (2010 - 2026)
Codexis (CDXS) recorded quarterly Payables of $2.1 million in Q1 2026, up 36.87% quarter-over-quarter from $1.6 million in Q4 2025, and down 64.82% on a YoY basis from $6.0 million in Q1 2025.
Codexis (CDXS) Payables (2010 - 2026) Analysis & Trends
Codexis' Payables history runs 17 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- In Q1 2026, Payables fell 64.82% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (down 64.82% YoY), while the FY2025 annual figure was $1.6 million, down 45.24% from the prior year.
- Payables was $2.1 million for Q1 2026 at Codexis, up from $1.6 million in the prior quarter.
- In the past five years, Payables ranged from a high of $6.0 million in Q1 2025 to a low of $1.5 million in Q2 2025.
- Historically, Payables has averaged $3.2 million across 5 years, with a median of $3.1 million in 2023.
- The sharpest annual moves came in 2023 and 2026: Payables surged 130.58% in 2023, then tumbled 64.82% in 2026.
- A 5-year view of Payables shows it stood at $3.2 million in 2022, then jumped by 83.21% to $5.9 million in 2023, then slumped by 52.28% to $2.8 million in 2024, then slumped by 45.24% to $1.6 million in 2025, then jumped by 36.87% to $2.1 million in 2026.
- The last three Payables figures came in at $2.1 million (Q1 2026), $1.6 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 34.55 Mn |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | 2.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.13 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | 2.43 Mn |
| Jun 30, 2025 | 1.47 Mn |
| Mar 31, 2025 | 6.05 Mn |
| Dec 31, 2024 | 2.84 Mn |
| Sep 30, 2024 | 4.21 Mn |
| Jun 30, 2024 | 3.69 Mn |
| Mar 31, 2024 | 3.47 Mn |
| Dec 31, 2023 | 5.95 Mn |
| Sep 30, 2023 | 3.10 Mn |
| Jun 30, 2023 | 4.04 Mn |
| Mar 31, 2023 | 4.49 Mn |
| Dec 31, 2022 | 3.25 Mn |
| Sep 30, 2022 | 2.62 Mn |
| Jun 30, 2022 | 2.02 Mn |
| Mar 31, 2022 | 1.95 Mn |
| Dec 31, 2021 | 3.00 Mn |
| Sep 30, 2021 | 3.28 Mn |
| Jun 30, 2021 | 3.16 Mn |